Human Alpha-1-acid glycoprotein 1(ORM1) ELISA kit

Code CSB-EL017237HU
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
orosomucoid 1
Alternative Names
A1AG1_HUMAN ELISA Kit; AGP 1 ELISA Kit; AGP A ELISA Kit; AGP ELISA Kit; AGP1 ELISA Kit; Alpha 1 acid glycoprotein ELISA Kit; Alpha-1-acid glycoprotein 1 ELISA Kit; alpha-1-AGP ELISA Kit; Epididymis secretory sperm binding protein Li 153w ELISA Kit; glycoprotein; alpha-1-acid; of serum ELISA Kit; HEL S 153w ELISA Kit; OMD 1 ELISA Kit; ORM ELISA Kit; ORM1 ELISA Kit; Orosomucoid 1 ELISA Kit; Orosomucoid-1 ELISA Kit
Abbreviation
ORM1
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates
Detection Range
31.25 ng/mL-2000 ng/mL
Sensitivity
7.8 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Immunology
Assay Principle
quantitative
Measurement
Competitive
Precision
Intra-assay Precision (Precision within an assay): CV%<8%      
Three samples of known concentration were tested twenty times on one plate to assess.  
Inter-assay Precision (Precision between assays): CV%<10%      
Three samples of known concentration were tested in twenty assays to assess.    
             
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human ORM1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)  
1:100 Average % 100  
Range % 92-104  
1:200 Average % 87  
Range % 82-91  
1:400 Average % 94  
Range % 91-97  
1:800 Average % 96  
Range % 92-100  
Recovery
The recovery of human ORM1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range  
Serum (n=5) 93 87-97  
EDTA plasma (n=4) 96 90-101  
             
             
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
ng/ml OD1 OD2 Average    
2000 0.140 0.134 0.137    
1000 0.415 0.434 0.425    
500 0.806 0.770 0.788    
250 1.068 1.011 1.040    
125 1.467 1.445 1.456    
62.5 1.686 1.634 1.660    
31.25 1.832 1.788 1.810    
0 2.027 1.994 2.011    
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Human ORM1 ELISA Kit was designed for the quantitative measurement of Human ORM1 protein in serum, plasma, tissue homogenates. It is a Competitive ELISA kit, its detection range is 31.25 ng/mL-2000 ng/mL and the sensitivity is 7.8 ng/mL.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction.
Gene References into Functions
  1. Studies suggest plasma alpha-1-acid glycoprotein (AAG) as a potential predictive biomarker of docetaxel non-haematological AEs namely oral mucositis and rash. PMID: 28554261
  2. Data provide evidence that Orm1 is induced in response to hepatic injury and executes liver regeneration by activating cell cycle progression in hepatocytes. PMID: 28927749
  3. Data suggest that serum haptoglobin, fetuin-A, platelet factor-4, hs-CRP (high sensitive-C-reactive protein), SAP (serum amyloid P), AGP (alpha1-acid glycoprotein) levels of adolescents with metabolic syndrome are significantly higher than those of controls subjects. PMID: 27754964
  4. Results indicate that advanced extranodal NK/T cell lymphoma (ENKL) patients with unfavourable treatment outcomes displayed higher levels of S100A9 and ORM1. PMID: 27021626
  5. Glycosylated Alpha-1-acid glycoprotein 1 is ostensibly expressed in lung cancer patients and is a potential lung cancer serum biomarker. PMID: 26563422
  6. Altogether, these results indicate that alpha1-3 fucosylated glycoforms of AGP are increased in PDAC and could be potentially regarded as a PDAC biomarker. PMID: 26563517
  7. The results of this study suggest that the expression of VEGF-A and ORM-1 may be associated with two mechanisms (angiogenesis and tumor structural viscosity) that may influence tumor growth in odontogenic myxoma. PMID: 26193215
  8. Data suggest that human serum albumin (HSA) might serve as a carrier in delivering chitooligomers to target tissues than alpha-1-glycoprotein (AGP) which has pharmacological importance PMID: 24359035
  9. ORM1 stimulates quiescent monocytes to polarize to M2b monocytes. PMID: 25689617
  10. Identify ORM genetic variations/haplotype structure associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients. PMID: 21638284
  11. Data indicate that the band intensity of sialic acid content in alpha-1 Acid glycoprotein (AGP) of alcoholic liver cirrhosis was found to be lower than that in pooled control group. PMID: 25408356
  12. These findings suggest that the ORM distal promoter region differentially regulates expression of ORM genes at basal level and in acute phase responses. PMID: 24389491
  13. Identified is the ORM1 gene, coding for orosomucoid, as a novel locus associated with lag time variability, reflecting the initiation process of thrombin generation. PMID: 24357727
  14. analysing the glycosylation of AGP in patients receiving methadone may aid in determining whether the therapy is likely to be effective. PMID: 23936770
  15. The ORM1 A113G polymorphism was associated with the PKs variability after taking telmsiartan, as well as ABCC2 C3972T. The heterozygotes of ORM1 113AG showed a larger AUC and a notable BP change(%) from the baseline compared with the wild-type. PMID: 23940561
  16. The ORM1 may be considered as a signaling molecule involved in the maintenance of tissue homeostasis and remodeling. PMID: 23973664
  17. A cross-sectional study was conducted to evaluate the relationship between periodontitis and the common systemic inflammatory markers in 32 morbidly obese patients. The severity of periodontitis was associated with the plasma level of orosomucoid. PMID: 23526947
  18. Drug-binding energetics of human alpha-1-acid glycoprotein. PMID: 23192962
  19. AGP has a direct effect in brain microvasculature and may play an important role in altering blood brain barrier integrity in inflammatory-related diseases. PMID: 22633841
  20. alpha(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress. PMID: 22807450
  21. change of the maintenance of three acute phase proteins: ceruloplasmin, alpha1-antitripsin and orosomucoid in an oral fluid and blood plasma at paradontitis and myocardial infarction PMID: 22708402
  22. Analyses of Nicaraguan population surveillance data suggest that preschool children with elevated AGP1 levels have higher prevalence of anemia than children with normal AGP1 levels. PMID: 22908695
  23. The binding properties of the polymyxin class of antibiotics for human alpha-1-acid glycoprotein (AGP) have been characterized. PMID: 22587817
  24. Urinary MCP1 and AGP are biomarkers of lupus nephritis in patients with juvenile-onset systemic lupus erythematosus, providing insight into its pathophysiology PMID: 22147846
  25. Characterization of 6-mercaptopurine binding site on human alpha1-acid glycoprotein (orosomucoid) using molecular docking. PMID: 22574522
  26. Leukocytospermia was associated with the alterations of terminal monosaccharide expression in human seminal fibronectin and alpha{1}-acid glycoprotein PMID: 22048274
  27. In this study, the potential of CZE-UV and CZE-ESI-MS analysis of intact AGP isoforms to study the correlation of this protein with bladder cancer is shown. PMID: 22216449
  28. Importance of pH and disulfide bridges on the structural and binding properties of human alpha-acid glycoprotein. PMID: 21621584
  29. Data suggest that GDC-0449 pharmacokinetics are mediated by AAG binding. PMID: 21300760
  30. The distribution of the AGP phenotypes did not differ significantly among the disease groups studied PMID: 21726491
  31. analysis of differences in drug-binding selectivity between two forms of human alpha1-acid glycoprotein genetic variants, the A and F1*S forms PMID: 21349832
  32. Characterized are more than 150 human Alpha-1-acid glycoprotein isoforms, differing both in the amino acid sequence and in the glycosylation. PMID: 20617306
  33. Almost all of the acute-phase proteins were closely related to rheumatoid arthritis activity (based on DAS28) and their places in the downgrade scale were as follows: CRP, Tf, AGP, Hp and AAT. PMID: 20371432
  34. ORM integrates inflammatory and metabolic signals to modulate immune responses to protect adipose tissue from excessive inflammation and thereby from metabolic dysfunction. PMID: 20442402
  35. ORM1*S/*S genotype predicted failure to complete a 6-week trial of antidepressants, whereas elevated plasma concentration of orosomucoid predicted failure to respond to antidepressant therapy at 6 weeks. PMID: 19395425
  36. The present study investigated enhanced fucosylation of AGP in the sera of chronic hepatitis B (HBV-CH) and hepatitis B cirrhosis (HBV-LC) patients. PMID: 19459043
  37. A site-directed mutagenesis study of drug-binding selectivity in genetic variants of AGP1 is reported. PMID: 19198000
  38. Different ORM1 phenotypes may affect the disposition of quinidine PMID: 11814462
  39. demonstrate that orosomucoid and/or its glycoforms affects thyroid cell function in vitro and that it does so by influencing the second messenger cAMP probably by interacting directly with the TSH receptor PMID: 11911961
  40. The effect of alpha2,6-linked sialic acid on anti-IgM antibody-induced apoptosis in Ramos cells. PMID: 11925509
  41. folds as a highly symmetrical all-beta protein dominated by a single eight-stranded antiparallel beta-sheet PMID: 12480518
  42. exerts significant effects on the pharmacokinetics, plasma concentrations, and intracellular distribution of imatinib in chronic myeloid leukemia patients PMID: 12576428
  43. tertiary structure analysis PMID: 15013397
  44. Urinary levels are increaed in normoalbuminuric type 2 diabetic patients. PMID: 15111541
  45. the N-linked glycosylation pattern of AGP was explored PMID: 16261636
  46. The binding of coumarin enantiomers to ORM1 is studied. PMID: 16290938
  47. The drug binding site of AGP was gained from circular dichroism and electronic absorption spectra. PMID: 17321687
  48. Alpha-1-acid glycoprotein 1 may be an endogenous ligand for Siglec-5 as a signaling molecule that participates directly in the regulation of neutrophil responses. PMID: 17675532
  49. Different ORM1 genotypes affect the protein binding percentage and the concentration of serum free nortriptyline. PMID: 17944232
  50. A different distribution of the area percentage of AGP forms is observed when comparing samples from diseased and healthy individuals, the most acidic AGP forms being present in a higher proportion in the samples from cancer patients. PMID: 17987628

Show More

Hide All

Subcellular Location
Secreted.
Protein Families
Calycin superfamily, Lipocalin family
Tissue Specificity
Expressed by the liver and secreted in plasma.
Database Links

HGNC: 8498

OMIM: 138600

KEGG: hsa:5004

STRING: 9606.ENSP00000259396

UniGene: Hs.522356

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X